Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Licitra

Showing results (231-240 of 311) with videos related to

Pageof 32
Sort By:
Frontiers in Oncology|October 5, 2023
Current management and future challenges in salivary glands cancerLaura D Locati, Renata Ferrarotto, Lisa Licitra, et al.
Frontiers in Oncology|January 19, 2024
Dietary intervention for tertiary prevention in head and neck squamous cell carcinoma survivors: clinical and translational results of a randomized phase II trialStefano Cavalieri, Eleonora Bruno, Mara Serena Serafini, et al.
Diagnostics (Basel, Switzerland)|June 2, 2021
A CT-Based Radiomic Signature Can Be Prognostic for 10-Months Overall Survival in Metastatic Tumors Treated with Nivolumab: An Exploratory StudyValentina D A Corino, Marco Bologna, Giuseppina Calareso, et al.
Endocrine-Related Cancer|February 23, 2017
The EORTC module for quality of life in patients with thyroid cancer: phase IIISusanne Singer, Susan Jordan, Laura D Locati, et al.
Critical Reviews in Oncology/Hematology|July 19, 2015
Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors: Literature review and consensusElvio G Russi, Francesco Moretto, Monica Rampino, et al.
Cancer|June 28, 2019
Nivolumab treatment beyond RECIST-defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trialRobert Haddad, Fernando Concha-Benavente, George Blumenschein, et al.
Oral Oncology|May 26, 2025
The role of volumetry in sinonasal cancer response assessment to induction chemotherapy, results from two phase II non-randomized controlled prospective multicentric trials: SINTART-1 and SINTART-2Paolo Rondi, Davide Mattavelli, Vittorio Rampinelli, et al.
Endocrine-Related Cancer|January 5, 2018
Circulating miR-375 as a novel prognostic marker for metastatic medullary thyroid cancer patientsPaola Romeo, Carla Colombo, Roberta Granata, et al.
Head & Neck|March 4, 2025
Lenvatinib in Relapsed/Metastatic Adenoid Cystic Carcinoma: Real-World Data From 17 Italian CentersFrancesca Caspani, Stefano Cavalieri, Ester Orlandi, et al.
Cancers|October 17, 2020
Baseline MRI-Radiomics Can Predict Overall Survival in Non-Endemic EBV-Related Nasopharyngeal Carcinoma PatientsMarco Bologna, Valentina Corino, Giuseppina Calareso, et al.
Pageof 32

Showing results (231-240 of 311) with videos related to

Sort By:
Pageof 32
Frontiers in Oncology|October 5, 2023
Current management and future challenges in salivary glands cancerLaura D Locati, Renata Ferrarotto, Lisa Licitra, et al.
Frontiers in Oncology|January 19, 2024
Dietary intervention for tertiary prevention in head and neck squamous cell carcinoma survivors: clinical and translational results of a randomized phase II trialStefano Cavalieri, Eleonora Bruno, Mara Serena Serafini, et al.
Diagnostics (Basel, Switzerland)|June 2, 2021
A CT-Based Radiomic Signature Can Be Prognostic for 10-Months Overall Survival in Metastatic Tumors Treated with Nivolumab: An Exploratory StudyValentina D A Corino, Marco Bologna, Giuseppina Calareso, et al.
Endocrine-Related Cancer|February 23, 2017
The EORTC module for quality of life in patients with thyroid cancer: phase IIISusanne Singer, Susan Jordan, Laura D Locati, et al.
Critical Reviews in Oncology/Hematology|July 19, 2015
Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors: Literature review and consensusElvio G Russi, Francesco Moretto, Monica Rampino, et al.
Cancer|June 28, 2019
Nivolumab treatment beyond RECIST-defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trialRobert Haddad, Fernando Concha-Benavente, George Blumenschein, et al.
Oral Oncology|May 26, 2025
The role of volumetry in sinonasal cancer response assessment to induction chemotherapy, results from two phase II non-randomized controlled prospective multicentric trials: SINTART-1 and SINTART-2Paolo Rondi, Davide Mattavelli, Vittorio Rampinelli, et al.
Endocrine-Related Cancer|January 5, 2018
Circulating miR-375 as a novel prognostic marker for metastatic medullary thyroid cancer patientsPaola Romeo, Carla Colombo, Roberta Granata, et al.
Head & Neck|March 4, 2025
Lenvatinib in Relapsed/Metastatic Adenoid Cystic Carcinoma: Real-World Data From 17 Italian CentersFrancesca Caspani, Stefano Cavalieri, Ester Orlandi, et al.
Cancers|October 17, 2020
Baseline MRI-Radiomics Can Predict Overall Survival in Non-Endemic EBV-Related Nasopharyngeal Carcinoma PatientsMarco Bologna, Valentina Corino, Giuseppina Calareso, et al.
Pageof 32